Abiopharma

Mereo BioPharma Provides Corporate Update

TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

(10% Negative) Mereo BioPharma (MREO) Announces Delay in setrusumab Trials for osteogenesis imperfecta Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Neutral) InnovAge Holding Corp (INNV) Reports Q1 2026 Financial Results

(10% Negative) Vir Biotechnology (VIR) Announces Delay in trial Trials for chronic hepatitis delta (CHD) Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

New Form 10-K - Medicale Corp. Filed: 2026-01-12 AccNo: 0001683168-26-000203 Size: 2 MB

(99% Positive) Cerus Corporation (CERS) Announces Clinical Development Update

Avantor, Inc. - Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026

Geron - Geron Corporation Provides 2026 Financial Guidance

BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation

Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026

Rigel Provides Business Update and 2026 Outlook